30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Chris Lowe

Track

Insider profile

Currently holds positions in Diadexus Inc and Quince Therapeutics Inc

Performance

Overall performance
0.8
Performance over holding periods
0.8
30 days 90 days 120 days
Average return -37% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Accounting Officer Diadexus Inc March 2, 2015 -
Chief Financial Officer, Treasurer Quince Therapeutics Inc April 1, 2019 -
Chief Financial Officer Quince Therapeutics Inc Jan. 1, 2019 - April 1, 2019
Interim Chief Financial Officer Quince Therapeutics Inc June 1, 2018 - Jan. 1, 2019
Interim Chief Financial Officer, Chief Accounting Officer Diadexus Inc Dec. 22, 2014 - March 2, 2015
Chief Financial Officer, Chief Business Officer Anthera Pharmaceuticals Inc Feb. 1, 2011 - June 30, 2013
Chris Lowe's trades of Vincerx Pharma Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-26 2022-08-25
B Purchase
81,254 -39.8%
156.39
US$3,764,121 		81,254 -39.8% 156.39 US$3,764,121
2022-08-26 2022-08-24
B Purchase
19,393 -49.8%
43.95
US$3,450,083 		19,393 -49.8% 43.95 US$3,450,083
2021-10-07 2021-10-05
PlS Planned sale
52,917 -36.9%
246.39
US$2,493,634 		52,917 -36.9% 246.39 US$2,493,634